Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Healthtrust
Moodys
Accenture
Covington
Julphar
Chubb
Cerilliant
McKinsey

Generated: November 20, 2018

DrugPatentWatch Database Preview

Flurazepam hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for flurazepam hydrochloride and what is the scope of flurazepam hydrochloride patent protection?

Flurazepam hydrochloride is the generic ingredient in two branded drugs marketed by Valeant Pharm Intl, Aurolife Pharma Llc, Halsey, Hikma Intl Pharms, Hikma Pharms, Mylan Pharms Inc, Par Pharm, Purepac Pharm, Sun Pharm Industries, Superpharm, Usl Pharma, Warner Chilcott, and Watson Labs, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for flurazepam hydrochloride. Six suppliers are listed for this compound.

Pharmacology for flurazepam hydrochloride
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for flurazepam hydrochloride
Synonyms for flurazepam hydrochloride
(S)-N-((2S,4S,5S)-5-(2-(2,6-dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxo-tetrahydropyrimidin-1(2H)-yl)butanamide
1172-18-5
1172-18-5 (di-hydrochloride)
17617-23-1
17617-23-1 (Parent)
191044-EP2275420A1
191044-EP2280008A2
2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-, dihydrochloride
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-, 1,3-dihydro-, dihydrochloride
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-,1,3-dihydro-, dihydrochloride
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-
2H-1,4-Benzodiazepin-2-one,7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-, dihydrochloride
36105-20-1 (mono-hydrochloride)
5-24-04-00322 (Beilstein Handbook Reference)
617F231
7-chloranyl-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one
7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one, dihydrochloride
7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1H-1,4-benzodiazepin-2(3H)-one
7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one
7-Chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one dihydrochloride
7-chloro-1-(2-diethylaminoethyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one
7-chloro-1-(2-diethylaminoethyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one dihydrochloride
7-Chloro-1-(diethylamino)ethyl-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2(1H)-one dihydrochloride
7-Chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-Chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one #
7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one
7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one
7-Chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
756RDM536M
A812156
AC1L1FU2
AC1L23TS
AKOS015889971
AN-5395
Benozil
BRN 0767925
C-21488
CAS-17617-23-1
CC-28512
CHEBI:5128
CHEBI:5129
CHEMBL968
D00329
D00695
D08XFV
Dalmadorm
Dalmadorm (TN)
Dalmane
Dalmane (TN)
Dalmane-R
Dalmate
DB00690
DEA No. 2767
DSSTox_CID_3071
DSSTox_GSID_23071
DSSTox_RID_76863
DTXSID1023071
DTXSID3025334
EINECS 214-630-0
EINECS 241-591-7
Felison
Felmane
Flunox
flurazepam
Flurazepam (JAN/INN)
Flurazepam (JP15/INN)
Flurazepam [INN:BAN:JAN]
Flurazepam 0.1 mg/ml in Methanol
Flurazepam 1.0 mg/ml in Methanol
Flurazepam dihydrochloride
FLURAZEPAM DIHYDROCHLORIDE (SEE ALSO FLURAZEPAM (17617-23-1))
flurazepam dihydrochloride--dea*schedule iv item
Flurazepam dihydrochloride, drug standard, 1.0 mg/mL in methanol
Flurazepam dihydrochloride, solid
Flurazepam HCL
Flurazepam hydrochloride (USP)
Flurazepam hydrochloride [USAN:JAN]
Flurazepam hydrochloride [USAN:USP:JAN]
Flurazepam hydrochloride, United States Pharmacopeia (USP) Reference Standard
Flurazepam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Flurazepam-D4 solution, 100 mug/mL in methanol, certified reference material
Flurazepamum
Flurazepamum [INN-Latin]
FT-0603548
FT-0630442
GTPL7188
HE069336
HSDB 3085
ID 480
IHP475989U
Insumin
Insumin (TN)
Insumin dihydrochloride
Linzac
LS-34188
LS-595
Lunipax
Natam
NCGC00164573-01
NCGC00164573-02
Noctosom
NSC-78559
Paxane
Ro 5-6901
Ro 56901/3
Ro-5-6901
Ro-5-6901/3
Ro-56901
SAADBVWGJQAEFS-UHFFFAOYSA-N
SCHEMBL29792
SCHEMBL29793
Somlan
Somnol
Stauroderm
Tox21_112201
Tox21_112201_1
UNII-756RDM536M
UNII-IHP475989U
Valdorm
W-108568
ZINC537752

US Patents and Regulatory Information for flurazepam hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071205-001 Nov 25, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071068-001 Nov 25, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Halsey FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071808-001 Jan 7, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Warner Chilcott FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071768-001 Dec 4, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for flurazepam hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharm Intl DALMANE flurazepam hydrochloride CAPSULE;ORAL 016721-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl DALMANE flurazepam hydrochloride CAPSULE;ORAL 016721-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Healthtrust
Moodys
Accenture
Covington
Julphar
Chubb
Cerilliant
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.